Utilizing TuneLab AI Models to Access Lilly-Trained Resources & Overcome Challenges in Drug Discovery

• Understanding that AI and ML models require large amounts of data to produce reliable results, often inaccessible to biotech companies
• Laying out the TuneLab toolbox with access to Lilly-trained AI models across biologic modalities to accelerate privacy-preserving drug discovery programs
• Exploring real-world examples of partners leveraging TuneLabs to accelerate internal drug discovery programs 

Speakers:

Vanessa Braunstein

Senior Director, TuneLab AI Drug Discovery Platform Ecosystem Growth

Eli Lilly & Co.